Cancer23

Introducing a new personalised approach to cancer treatment pathways.

23Strands Cancer

We have partnered with the leading genomics providers to provide clinicians with personalised insights into alternative treatment options concerning their cancer patients.

OUR CAPABILITIES

Deep and extensive tumour gene expression analysis can generate relevant data that reveals possible targets for precision drug therapy.
Comprehensive genetic profiling of tumour tissue
Evaluate the effectiveness of responses and reactions to chemotherapy drugs
Provide efficacy and resistance guidance for chemotherapy
Deliver a non-invasive biopsy diagnostic tool through blood samples as an alternative substitute to invasive tissue extraction.

Research Documents

Files for Patients

Files for Doctors

Latest News

Keep up to date with the latest genomics news

Monday, May 8, 2023

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer

23Strands is standing in solidarity in the fight against ovarian cancer. Ovarian cancer remains one of the most fatal cancers affecting women. Globally, a woman or girl who is diagnosed with ovarian cancer faces a 49% chance of surviving the next five years. Despite this, research in ovarian cancer persists to be disproportionately low in comparison to other fields of oncology.